

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.58561341 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.58561341 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.37867374 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.37867374 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.71678301 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.40362826 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.09514013 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.09514013 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.98317316 |
| 10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.92606065 |
| 11 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.86936256 |
| 12 | regulation of regulatory T cell differentiation (GO:0045589) | 3.68210797 |
| 13 | protein retention in ER lumen (GO:0006621) | 3.67289140 |
| 14 | positive regulation of lamellipodium assembly (GO:0010592) | 3.65929754 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57449392 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.56359412 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.46751181 |
| 18 | regulation of translational termination (GO:0006449) | 3.42562719 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.42204945 |
| 20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38077566 |
| 21 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.34786492 |
| 22 | tricarboxylic acid metabolic process (GO:0072350) | 3.34077176 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.33632145 |
| 24 | positive regulation of nuclease activity (GO:0032075) | 3.31507766 |
| 25 | regulation of RIG-I signaling pathway (GO:0039535) | 3.27614204 |
| 26 | oxaloacetate metabolic process (GO:0006107) | 3.25635625 |
| 27 | positive regulation of histone deacetylation (GO:0031065) | 3.25451971 |
| 28 | cytidine deamination (GO:0009972) | 3.25121264 |
| 29 | cytidine metabolic process (GO:0046087) | 3.25121264 |
| 30 | cytidine catabolic process (GO:0006216) | 3.25121264 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22977676 |
| 32 | negative T cell selection (GO:0043383) | 3.16101996 |
| 33 | vesicle coating (GO:0006901) | 3.10737060 |
| 34 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06277516 |
| 35 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.06092396 |
| 36 | positive regulation of lamellipodium organization (GO:1902745) | 3.04685445 |
| 37 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.03967143 |
| 38 | regulation of chronic inflammatory response (GO:0002676) | 3.03568735 |
| 39 | regulation of nuclease activity (GO:0032069) | 3.01459884 |
| 40 | protein autoprocessing (GO:0016540) | 3.00160516 |
| 41 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.96087383 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95578321 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94028720 |
| 44 | positive thymic T cell selection (GO:0045059) | 2.93891665 |
| 45 | regulation of response to interferon-gamma (GO:0060330) | 2.89939168 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89510841 |
| 47 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88696474 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 2.87548275 |
| 49 | response to interferon-beta (GO:0035456) | 2.86235004 |
| 50 | pentose-phosphate shunt (GO:0006098) | 2.86014533 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.85008326 |
| 52 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.84177209 |
| 53 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.83350677 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82776541 |
| 55 | neutrophil activation (GO:0042119) | 2.81892935 |
| 56 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.81622682 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.81622682 |
| 58 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79778023 |
| 59 | negative regulation of T cell apoptotic process (GO:0070233) | 2.76201509 |
| 60 | barbed-end actin filament capping (GO:0051016) | 2.75034411 |
| 61 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.74148567 |
| 62 | cellular response to unfolded protein (GO:0034620) | 2.73740760 |
| 63 | cellular response to type I interferon (GO:0071357) | 2.73120901 |
| 64 | type I interferon signaling pathway (GO:0060337) | 2.73120901 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 2.70531418 |
| 66 | granulocyte activation (GO:0036230) | 2.70506996 |
| 67 | positive regulation of protein deacetylation (GO:0090312) | 2.70289246 |
| 68 | thymic T cell selection (GO:0045061) | 2.69980834 |
| 69 | response to type I interferon (GO:0034340) | 2.69710765 |
| 70 | necroptotic process (GO:0070266) | 2.69259646 |
| 71 | tolerance induction (GO:0002507) | 2.68743311 |
| 72 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.67906541 |
| 73 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.67569083 |
| 74 | response to interleukin-15 (GO:0070672) | 2.67045114 |
| 75 | positive regulation of macrophage differentiation (GO:0045651) | 2.67006766 |
| 76 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66795865 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.65907631 |
| 78 | cellular response to topologically incorrect protein (GO:0035967) | 2.65494934 |
| 79 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.64753465 |
| 80 | regulation of defense response to virus by virus (GO:0050690) | 2.64667384 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.63898159 |
| 82 | COPII vesicle coating (GO:0048208) | 2.63711383 |
| 83 | protein maturation by protein folding (GO:0022417) | 2.63219524 |
| 84 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.63024424 |
| 85 | actin nucleation (GO:0045010) | 2.61479169 |
| 86 | ER-nucleus signaling pathway (GO:0006984) | 2.58449926 |
| 87 | sexual reproduction (GO:0019953) | 2.58190319 |
| 88 | negative regulation of cell size (GO:0045792) | 2.56986281 |
| 89 | natural killer cell differentiation (GO:0001779) | 2.56860694 |
| 90 | dendritic cell chemotaxis (GO:0002407) | 2.56362400 |
| 91 | organelle membrane fusion (GO:0090174) | 2.56087352 |
| 92 | positive regulation of B cell mediated immunity (GO:0002714) | 2.55484404 |
| 93 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.55484404 |
| 94 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.55381920 |
| 95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.55381920 |
| 96 | signal peptide processing (GO:0006465) | 2.54807464 |
| 97 | lymphocyte chemotaxis (GO:0048247) | 2.53762767 |
| 98 | T cell migration (GO:0072678) | 2.52189962 |
| 99 | B cell mediated immunity (GO:0019724) | 2.51818425 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 2.51614918 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 2.50229532 |
| 102 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.47845398 |
| 103 | negative regulation of T cell mediated immunity (GO:0002710) | 2.46984795 |
| 104 | T cell apoptotic process (GO:0070231) | 2.46743144 |
| 105 | NADH metabolic process (GO:0006734) | 2.46231218 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.45506762 |
| 107 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.45330919 |
| 108 | interferon-gamma production (GO:0032609) | 2.45158121 |
| 109 | positive regulation of tolerance induction (GO:0002645) | 2.44639482 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.44283048 |
| 111 | dendritic cell migration (GO:0036336) | 2.43303045 |
| 112 | positive regulation of defense response to virus by host (GO:0002230) | 2.43198576 |
| 113 | autophagic vacuole fusion (GO:0000046) | 2.40591920 |
| 114 | regulation of germinal center formation (GO:0002634) | 2.39255897 |
| 115 | positive regulation of humoral immune response (GO:0002922) | 2.38299255 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37957753 |
| 117 | NADPH regeneration (GO:0006740) | 2.37791406 |
| 118 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.37582681 |
| 119 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.36705903 |
| 120 | T cell selection (GO:0045058) | 2.36325805 |
| 121 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35933887 |
| 122 | execution phase of apoptosis (GO:0097194) | 2.35698962 |
| 123 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.35482018 |
| 124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.34083510 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.33760825 |
| 126 | regulation of protein heterodimerization activity (GO:0043497) | 2.33004420 |
| 127 | regulation of cell killing (GO:0031341) | 2.32682015 |
| 128 | maternal placenta development (GO:0001893) | 2.32402472 |
| 129 | regulation of metalloenzyme activity (GO:0048552) | 2.31504468 |
| 130 | positive regulation of cell killing (GO:0031343) | 2.31449829 |
| 131 | leukocyte degranulation (GO:0043299) | 2.31444478 |
| 132 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.31375111 |
| 133 | positive regulation of T cell mediated immunity (GO:0002711) | 2.28945734 |
| 134 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.28391523 |
| 135 | morphogenesis of an endothelium (GO:0003159) | 2.28316897 |
| 136 | endothelial tube morphogenesis (GO:0061154) | 2.28316897 |
| 137 | thrombin receptor signaling pathway (GO:0070493) | 2.28201754 |
| 138 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.27742591 |
| 139 | galactose catabolic process (GO:0019388) | 2.27582502 |
| 140 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.26732915 |
| 141 | negative regulation of viral genome replication (GO:0045071) | 2.26635662 |
| 142 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.25846419 |
| 143 | positive regulation of DNA recombination (GO:0045911) | 2.24978669 |
| 144 | positive regulation of T cell cytokine production (GO:0002726) | 2.24376026 |
| 145 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.24359780 |
| 146 | positive T cell selection (GO:0043368) | 2.24343727 |
| 147 | virion assembly (GO:0019068) | 2.24249920 |
| 148 | membrane raft organization (GO:0031579) | 2.23602509 |
| 149 | cellular response to zinc ion (GO:0071294) | 2.23427813 |
| 150 | platelet aggregation (GO:0070527) | 2.22925396 |
| 151 | lysine catabolic process (GO:0006554) | 2.22888934 |
| 152 | lysine metabolic process (GO:0006553) | 2.22888934 |
| 153 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22454017 |
| 154 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.22448763 |
| 155 | positive regulation of T cell chemotaxis (GO:0010820) | 2.21668703 |
| 156 | regulation of T cell chemotaxis (GO:0010819) | 2.21668703 |
| 157 | T cell costimulation (GO:0031295) | 2.21558497 |
| 158 | lymphocyte costimulation (GO:0031294) | 2.21529446 |
| 159 | positive regulation of isotype switching (GO:0045830) | 2.21256131 |
| 160 | sequestering of metal ion (GO:0051238) | 2.21075949 |
| 161 | valine metabolic process (GO:0006573) | 2.21043586 |
| 162 | regulation of T cell tolerance induction (GO:0002664) | 2.17207084 |
| 163 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.16632795 |
| 164 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.15629229 |
| 165 | hepatocyte apoptotic process (GO:0097284) | 2.15124810 |
| 166 | mannose metabolic process (GO:0006013) | 2.14408122 |
| 167 | DNA deamination (GO:0045006) | 2.14112706 |
| 168 | T cell proliferation (GO:0042098) | 2.14070245 |
| 169 | cellular response to interleukin-15 (GO:0071350) | 2.14012907 |
| 170 | positive regulation of immune response to tumor cell (GO:0002839) | 2.13842568 |
| 171 | regulation of immune response to tumor cell (GO:0002837) | 2.13842568 |
| 172 | regulation of response to tumor cell (GO:0002834) | 2.13842568 |
| 173 | positive regulation of response to tumor cell (GO:0002836) | 2.13842568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22759154 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.07678480 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.02423121 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.00883107 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87748183 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.86077731 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83451467 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77283706 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65311049 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35755953 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30797338 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.28403335 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15605059 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11916601 |
| 15 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01509397 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98587267 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.96959806 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96881762 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 1.96374126 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94661549 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92520284 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91173556 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90761751 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.90355526 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88801271 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88468787 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87166584 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84837229 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84102628 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81175951 |
| 31 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.80741093 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80729855 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77084942 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75001704 |
| 35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.74010412 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71516114 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70285323 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69377152 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68823304 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67329478 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65472278 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65241184 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63152571 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60034859 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.60003721 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59789746 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58720446 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57699014 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56596201 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56460295 |
| 51 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.55643676 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55427151 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55308077 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53560128 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53216498 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51061684 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49831546 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49472599 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48185407 |
| 60 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46809988 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45484386 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44953780 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44860211 |
| 64 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.44292618 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43892847 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43560103 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43514785 |
| 68 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41804331 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41598850 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40971310 |
| 71 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.40809445 |
| 72 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40376425 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40103174 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38423962 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38364485 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37652701 |
| 77 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.37009245 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33342423 |
| 79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32530860 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31006965 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30623160 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.30299737 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30204152 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26611550 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25147674 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24787051 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24333036 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24215986 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24134904 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22723752 |
| 91 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21780970 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20855140 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.20127459 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19108068 |
| 95 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16866972 |
| 96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.14608489 |
| 97 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13724284 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11883565 |
| 99 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11850515 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11124006 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09624958 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09416328 |
| 103 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08650826 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07032961 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06659658 |
| 106 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06419490 |
| 107 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.06285746 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05529068 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04350620 |
| 110 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02826732 |
| 111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02371980 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00760768 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98481409 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98391368 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98283618 |
| 116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98275563 |
| 117 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98017013 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97725377 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95351239 |
| 120 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95182591 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94977963 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94904336 |
| 123 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94221148 |
| 124 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93409909 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92655970 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92126619 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90780556 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90759897 |
| 129 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90745532 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90578890 |
| 131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90081652 |
| 132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89441790 |
| 133 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88984392 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88957622 |
| 135 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88704202 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88195986 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86700314 |
| 138 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85366131 |
| 139 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84339473 |
| 140 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83851930 |
| 141 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83072518 |
| 142 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82898271 |
| 143 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82740960 |
| 144 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82000958 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81740649 |
| 146 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81593099 |
| 147 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.81314937 |
| 148 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81238653 |
| 149 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80735292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.23580670 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 2.93146602 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.75315563 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 2.63525311 |
| 5 | MP0006054_spinal_hemorrhage | 2.48152920 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.45716183 |
| 7 | MP0003436_decreased_susceptibility_to | 2.42528036 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.31210708 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.20989576 |
| 10 | MP0005360_urolithiasis | 2.18451614 |
| 11 | * MP0000685_abnormal_immune_system | 2.09492729 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.08934178 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.05703665 |
| 14 | MP0006082_CNS_inflammation | 2.04269160 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.03617985 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.02710487 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.02008325 |
| 18 | MP0005451_abnormal_body_composition | 1.91672810 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 1.81172462 |
| 20 | MP0003195_calcinosis | 1.79912661 |
| 21 | MP0001800_abnormal_humoral_immune | 1.72347894 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.72268694 |
| 23 | MP0003866_abnormal_defecation | 1.69716664 |
| 24 | MP0004947_skin_inflammation | 1.67519854 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.66408952 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 1.64679580 |
| 27 | MP0002398_abnormal_bone_marrow | 1.64438272 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.63129137 |
| 29 | MP0005671_abnormal_response_to | 1.60606089 |
| 30 | MP0009785_altered_susceptibility_to | 1.58749416 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.57802052 |
| 32 | MP0001853_heart_inflammation | 1.56768069 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.56447326 |
| 34 | MP0002006_tumorigenesis | 1.56176307 |
| 35 | MP0003303_peritoneal_inflammation | 1.55037253 |
| 36 | MP0001819_abnormal_immune_cell | 1.54972476 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.53893479 |
| 38 | MP0002723_abnormal_immune_serum | 1.50831165 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.50495235 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.49268252 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.48719441 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.48719441 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.48176509 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.47914426 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.47735067 |
| 46 | MP0001790_abnormal_immune_system | 1.46121228 |
| 47 | MP0005387_immune_system_phenotype | 1.46121228 |
| 48 | MP0009764_decreased_sensitivity_to | 1.45852250 |
| 49 | MP0005025_abnormal_response_to | 1.45252589 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.43549695 |
| 51 | MP0009278_abnormal_bone_marrow | 1.35449666 |
| 52 | MP0005365_abnormal_bile_salt | 1.35323749 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.33459413 |
| 54 | MP0000716_abnormal_immune_system | 1.30412682 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.30375548 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.30023742 |
| 57 | MP0001873_stomach_inflammation | 1.28845606 |
| 58 | MP0001756_abnormal_urination | 1.28777697 |
| 59 | MP0005083_abnormal_biliary_tract | 1.28420396 |
| 60 | MP0002419_abnormal_innate_immunity | 1.27024499 |
| 61 | MP0000604_amyloidosis | 1.26464984 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.25681488 |
| 63 | MP0002722_abnormal_immune_system | 1.25654547 |
| 64 | MP0000343_altered_response_to | 1.25391606 |
| 65 | MP0002405_respiratory_system_inflammati | 1.24482062 |
| 66 | * MP0000689_abnormal_spleen_morphology | 1.24190881 |
| 67 | MP0005408_hypopigmentation | 1.23606316 |
| 68 | MP0002429_abnormal_blood_cell | 1.22161500 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.22080852 |
| 70 | MP0003045_fibrosis | 1.21494683 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.21482658 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.20742187 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.20626309 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 1.20273252 |
| 75 | MP0000858_altered_metastatic_potential | 1.18494017 |
| 76 | MP0003828_pulmonary_edema | 1.18396123 |
| 77 | MP0003172_abnormal_lysosome_physiology | 1.16212506 |
| 78 | MP0010307_abnormal_tumor_latency | 1.15795228 |
| 79 | MP0009840_abnormal_foam_cell | 1.15483039 |
| 80 | MP0005165_increased_susceptibility_to | 1.15038357 |
| 81 | MP0000609_abnormal_liver_physiology | 1.14635415 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 1.14285281 |
| 83 | MP0002132_abnormal_respiratory_system | 1.14150082 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.13856746 |
| 85 | MP0009763_increased_sensitivity_to | 1.13405271 |
| 86 | MP0005166_decreased_susceptibility_to | 1.11701350 |
| 87 | MP0008004_abnormal_stomach_pH | 1.10563736 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10253272 |
| 89 | MP0005310_abnormal_salivary_gland | 1.09421479 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 1.09395794 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 1.08235021 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 1.07185779 |
| 93 | MP0008469_abnormal_protein_level | 1.06759979 |
| 94 | MP0003950_abnormal_plasma_membrane | 1.06173102 |
| 95 | MP0000372_irregular_coat_pigmentation | 1.04567414 |
| 96 | MP0000358_abnormal_cell_content/ | 1.03950789 |
| 97 | MP0003693_abnormal_embryo_hatching | 1.03816467 |
| 98 | MP0002933_joint_inflammation | 1.03718179 |
| 99 | MP0005023_abnormal_wound_healing | 1.03166854 |
| 100 | MP0004381_abnormal_hair_follicle | 1.02803298 |
| 101 | MP0001765_abnormal_ion_homeostasis | 1.02386775 |
| 102 | MP0003724_increased_susceptibility_to | 1.01486205 |
| 103 | MP0000015_abnormal_ear_pigmentation | 1.00941794 |
| 104 | MP0002148_abnormal_hypersensitivity_rea | 1.00657530 |
| 105 | MP0004883_abnormal_blood_vessel | 0.98250000 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.98023788 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.95855715 |
| 108 | MP0000490_abnormal_crypts_of | 0.95800221 |
| 109 | MP0002693_abnormal_pancreas_physiology | 0.95381483 |
| 110 | MP0003646_muscle_fatigue | 0.94970823 |
| 111 | MP0003091_abnormal_cell_migration | 0.94895096 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.94689481 |
| 113 | MP0001944_abnormal_pancreas_morphology | 0.93568826 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.92760843 |
| 115 | MP0004510_myositis | 0.92390938 |
| 116 | MP0005164_abnormal_response_to | 0.92120562 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.92022705 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.90686550 |
| 119 | MP0003075_altered_response_to | 0.90031509 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88629293 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.87534782 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.87186258 |
| 123 | * MP0002019_abnormal_tumor_incidence | 0.85264043 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.84129591 |
| 125 | MP0003329_amyloid_beta_deposits | 0.84055705 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.82458840 |
| 127 | MP0003252_abnormal_bile_duct | 0.81898373 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.80400761 |
| 129 | MP0000249_abnormal_blood_vessel | 0.80399828 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.80139449 |
| 131 | MP0003448_altered_tumor_morphology | 0.80059078 |
| 132 | MP0010329_abnormal_lipoprotein_level | 0.79317137 |
| 133 | MP0003186_abnormal_redox_activity | 0.78637297 |
| 134 | MP0001764_abnormal_homeostasis | 0.76667069 |
| 135 | MP0001663_abnormal_digestive_system | 0.75802001 |
| 136 | MP0004484_altered_response_of | 0.72803181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 3.62347865 |
| 2 | Recurrent bronchitis (HP:0002837) | 3.48583426 |
| 3 | Prolonged bleeding time (HP:0003010) | 3.29452738 |
| 4 | IgM deficiency (HP:0002850) | 3.20929417 |
| 5 | Purpura (HP:0000979) | 3.19765825 |
| 6 | Petechiae (HP:0000967) | 3.18031410 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17425293 |
| 8 | Long toe (HP:0010511) | 3.11929167 |
| 9 | Nasal polyposis (HP:0100582) | 3.05425151 |
| 10 | IgG deficiency (HP:0004315) | 3.04737293 |
| 11 | Recurrent abscess formation (HP:0002722) | 2.93307446 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 2.90457546 |
| 13 | Hand muscle atrophy (HP:0009130) | 2.88664602 |
| 14 | Increased IgM level (HP:0003496) | 2.87781243 |
| 15 | Abnormality of macrophages (HP:0004311) | 2.82330619 |
| 16 | Chronic diarrhea (HP:0002028) | 2.80899897 |
| 17 | Gingival bleeding (HP:0000225) | 2.73082075 |
| 18 | Menorrhagia (HP:0000132) | 2.72683636 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 2.72304793 |
| 20 | Epistaxis (HP:0000421) | 2.67056720 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.66879431 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.60184233 |
| 23 | Generalized aminoaciduria (HP:0002909) | 2.54976266 |
| 24 | Eosinophilia (HP:0001880) | 2.54604329 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.54557866 |
| 26 | Pulmonary infiltrates (HP:0002113) | 2.51819140 |
| 27 | Growth hormone excess (HP:0000845) | 2.51171499 |
| 28 | Hypoproteinemia (HP:0003075) | 2.48673593 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42067433 |
| 30 | Mucopolysacchariduria (HP:0008155) | 2.42067433 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42059395 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42059395 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42059395 |
| 34 | Thrombocytosis (HP:0001894) | 2.40419424 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.40313080 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.39478745 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.38644934 |
| 38 | Renal cortical cysts (HP:0000803) | 2.35831076 |
| 39 | Bronchitis (HP:0012387) | 2.35656576 |
| 40 | Granulocytopenia (HP:0001913) | 2.34573287 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.34279935 |
| 42 | Acute hepatic failure (HP:0006554) | 2.33353834 |
| 43 | Nausea (HP:0002018) | 2.31963084 |
| 44 | Upper limb amyotrophy (HP:0009129) | 2.31873681 |
| 45 | Distal upper limb amyotrophy (HP:0007149) | 2.31873681 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.30810049 |
| 47 | Myositis (HP:0100614) | 2.28248958 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.27690321 |
| 49 | Hepatic necrosis (HP:0002605) | 2.26484024 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25821366 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25821366 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25821366 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25321375 |
| 54 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24930882 |
| 55 | Abnormal platelet volume (HP:0011876) | 2.24680043 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.22284091 |
| 57 | Increased mean platelet volume (HP:0011877) | 2.21760295 |
| 58 | Encephalitis (HP:0002383) | 2.21350653 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.19948054 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.18064689 |
| 61 | Optic neuritis (HP:0100653) | 2.18064689 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.17826527 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.17732513 |
| 64 | Hypercortisolism (HP:0001578) | 2.16376018 |
| 65 | Papilloma (HP:0012740) | 2.15241470 |
| 66 | Verrucae (HP:0200043) | 2.15241470 |
| 67 | Tongue fasciculations (HP:0001308) | 2.14680912 |
| 68 | Recurrent skin infections (HP:0001581) | 2.14638548 |
| 69 | Muscle fibrillation (HP:0010546) | 2.13309944 |
| 70 | Abnormality of the thoracic spine (HP:0100711) | 2.12775251 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.12368328 |
| 72 | Gout (HP:0001997) | 2.12155553 |
| 73 | Chronic sinusitis (HP:0011109) | 2.11207375 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.11164161 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11138188 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11138188 |
| 77 | Recurrent viral infections (HP:0004429) | 2.10025646 |
| 78 | T lymphocytopenia (HP:0005403) | 2.08840390 |
| 79 | Meningitis (HP:0001287) | 2.08675803 |
| 80 | Polygenic inheritance (HP:0010982) | 2.06822795 |
| 81 | Late onset (HP:0003584) | 2.06643330 |
| 82 | Glucose intolerance (HP:0000833) | 2.06423211 |
| 83 | Papilledema (HP:0001085) | 2.05669860 |
| 84 | Chronic otitis media (HP:0000389) | 2.05147403 |
| 85 | Abnormality of the prostate (HP:0008775) | 2.04752034 |
| 86 | Ketoacidosis (HP:0001993) | 2.04385266 |
| 87 | Albinism (HP:0001022) | 2.03581148 |
| 88 | Palpitations (HP:0001962) | 2.03181584 |
| 89 | Striae distensae (HP:0001065) | 2.02660090 |
| 90 | Thoracolumbar scoliosis (HP:0002944) | 2.01771766 |
| 91 | Abnormality of T cells (HP:0002843) | 2.01007758 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.00381951 |
| 93 | Frequent falls (HP:0002359) | 2.00106805 |
| 94 | Hematochezia (HP:0002573) | 1.98174187 |
| 95 | Severe short stature (HP:0003510) | 1.98033655 |
| 96 | Leukocytosis (HP:0001974) | 1.97584507 |
| 97 | Hypoplasia of the thymus (HP:0000778) | 1.96339032 |
| 98 | Increased IgE level (HP:0003212) | 1.95836299 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.95489117 |
| 100 | Obstructive lung disease (HP:0006536) | 1.94806377 |
| 101 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94806377 |
| 102 | Vertebral arch anomaly (HP:0008438) | 1.93822166 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.93610123 |
| 104 | Polycythemia (HP:0001901) | 1.93497963 |
| 105 | Thyroiditis (HP:0100646) | 1.92530858 |
| 106 | Hepatocellular necrosis (HP:0001404) | 1.91664783 |
| 107 | Hypoglycemic coma (HP:0001325) | 1.90733535 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.90533260 |
| 109 | Pulmonary fibrosis (HP:0002206) | 1.90291057 |
| 110 | Arterial thrombosis (HP:0004420) | 1.90129185 |
| 111 | Mucosal telangiectasiae (HP:0100579) | 1.88230453 |
| 112 | Recurrent sinusitis (HP:0011108) | 1.87028880 |
| 113 | Resting tremor (HP:0002322) | 1.87022321 |
| 114 | Aortic aneurysm (HP:0004942) | 1.86744566 |
| 115 | Chest pain (HP:0100749) | 1.85803669 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.85138116 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84792614 |
| 118 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84565139 |
| 119 | Abnormality of B cell number (HP:0010975) | 1.84321976 |
| 120 | Hemoptysis (HP:0002105) | 1.82735802 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 1.82577847 |
| 122 | Episodic fever (HP:0001954) | 1.82080244 |
| 123 | Pustule (HP:0200039) | 1.81046941 |
| 124 | Vasculitis (HP:0002633) | 1.80455212 |
| 125 | Congenital stationary night blindness (HP:0007642) | 1.80180728 |
| 126 | Polyneuropathy (HP:0001271) | 1.79815141 |
| 127 | Nemaline bodies (HP:0003798) | 1.79080798 |
| 128 | Fatigue (HP:0012378) | 1.79031425 |
| 129 | Abnormality of T cell physiology (HP:0011840) | 1.78771746 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.78577396 |
| 131 | Thoracic kyphosis (HP:0002942) | 1.77148243 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.77014985 |
| 133 | Inflammation of the large intestine (HP:0002037) | 1.76993152 |
| 134 | Insomnia (HP:0100785) | 1.76914777 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76455069 |
| 136 | Diminished motivation (HP:0000745) | 1.76070925 |
| 137 | Increased serum ferritin (HP:0003281) | 1.75819611 |
| 138 | Hypergammaglobulinemia (HP:0010702) | 1.74735553 |
| 139 | Xanthomatosis (HP:0000991) | 1.72498209 |
| 140 | Orthostatic hypotension (HP:0001278) | 1.71274816 |
| 141 | Cellulitis (HP:0100658) | 1.70754874 |
| 142 | Spastic diplegia (HP:0001264) | 1.70609228 |
| 143 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.70417730 |
| 144 | Systemic lupus erythematosus (HP:0002725) | 1.68128471 |
| 145 | Generalized hyperpigmentation (HP:0007440) | 1.67606142 |
| 146 | Spinal muscular atrophy (HP:0007269) | 1.67462815 |
| 147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65480407 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 1.65126337 |
| 149 | Peritonitis (HP:0002586) | 1.65107870 |
| 150 | Combined immunodeficiency (HP:0005387) | 1.64880652 |
| 151 | Lymphopenia (HP:0001888) | 1.64731133 |
| 152 | Abnormality of the motor neurons (HP:0002450) | 1.64534451 |
| 153 | Abnormal neuron morphology (HP:0012757) | 1.64534451 |
| 154 | Orchitis (HP:0100796) | 1.64418076 |
| 155 | Tetraparesis (HP:0002273) | 1.64036271 |
| 156 | Death in childhood (HP:0003819) | 1.63776974 |
| 157 | Sensorimotor neuropathy (HP:0007141) | 1.63524562 |
| 158 | Abnormality of the lumbar spine (HP:0100712) | 1.63240194 |
| 159 | Global brain atrophy (HP:0002283) | 1.62603388 |
| 160 | Colitis (HP:0002583) | 1.62269180 |
| 161 | Aneurysm (HP:0002617) | 1.61727085 |
| 162 | Joint swelling (HP:0001386) | 1.61501497 |
| 163 | Myoglobinuria (HP:0002913) | 1.60833270 |
| 164 | Abnormal platelet function (HP:0011869) | 1.60750162 |
| 165 | Impaired platelet aggregation (HP:0003540) | 1.60750162 |
| 166 | Ketosis (HP:0001946) | 1.60289246 |
| 167 | IgA deficiency (HP:0002720) | 1.59384841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.85294539 |
| 2 | EEF2K | 3.58145915 |
| 3 | MST4 | 3.50150581 |
| 4 | ERN1 | 3.41549099 |
| 5 | MAP4K1 | 2.86117771 |
| 6 | PKN2 | 2.78712596 |
| 7 | MAP3K10 | 2.60487625 |
| 8 | SCYL2 | 2.31596635 |
| 9 | FGFR4 | 2.09954835 |
| 10 | TESK1 | 2.04340929 |
| 11 | FLT3 | 1.98140970 |
| 12 | ZAP70 | 1.95029838 |
| 13 | TYK2 | 1.93200887 |
| 14 | SIK3 | 1.89768432 |
| 15 | GRK6 | 1.86176313 |
| 16 | MAP3K13 | 1.84650442 |
| 17 | KDR | 1.83456661 |
| 18 | LRRK2 | 1.82100213 |
| 19 | ARAF | 1.80107352 |
| 20 | JAK3 | 1.79453613 |
| 21 | FES | 1.77379318 |
| 22 | TEC | 1.72962212 |
| 23 | BMPR2 | 1.70978731 |
| 24 | MYLK | 1.69283751 |
| 25 | MAP3K9 | 1.68873418 |
| 26 | TBK1 | 1.61903370 |
| 27 | PDK2 | 1.60556353 |
| 28 | MAP2K3 | 1.59292217 |
| 29 | IKBKB | 1.52646709 |
| 30 | FGFR3 | 1.50560887 |
| 31 | KSR2 | 1.49578195 |
| 32 | RIPK4 | 1.48775301 |
| 33 | JAK1 | 1.42080654 |
| 34 | CAMKK2 | 1.41241576 |
| 35 | MAP3K5 | 1.39616562 |
| 36 | TESK2 | 1.36286526 |
| 37 | * MAPKAPK3 | 1.35658706 |
| 38 | LIMK1 | 1.34243520 |
| 39 | IRAK4 | 1.25247159 |
| 40 | TRIM28 | 1.25086372 |
| 41 | GRK1 | 1.23337538 |
| 42 | PTK6 | 1.21864233 |
| 43 | RIPK1 | 1.16804827 |
| 44 | TTN | 1.16324455 |
| 45 | FER | 1.16050527 |
| 46 | PASK | 1.12760480 |
| 47 | DYRK1B | 1.09371856 |
| 48 | LYN | 1.08207501 |
| 49 | ERBB3 | 1.08140382 |
| 50 | JAK2 | 1.06956018 |
| 51 | IRAK3 | 1.06508591 |
| 52 | TAOK2 | 1.05830390 |
| 53 | RAF1 | 1.00970746 |
| 54 | KSR1 | 1.00343391 |
| 55 | MAP3K12 | 0.99723233 |
| 56 | PIM2 | 0.99017900 |
| 57 | PTK2B | 0.98916606 |
| 58 | RET | 0.98203017 |
| 59 | MAP3K11 | 0.93959435 |
| 60 | SYK | 0.93697889 |
| 61 | PIK3CG | 0.91266801 |
| 62 | NLK | 0.90719736 |
| 63 | PAK4 | 0.89945701 |
| 64 | MAPK11 | 0.89459486 |
| 65 | KIT | 0.88364816 |
| 66 | TAOK1 | 0.87939203 |
| 67 | CSF1R | 0.86113343 |
| 68 | BCKDK | 0.83227131 |
| 69 | WNK3 | 0.82251889 |
| 70 | BTK | 0.82229152 |
| 71 | STK10 | 0.81927503 |
| 72 | MARK3 | 0.81291737 |
| 73 | PRKCQ | 0.80320240 |
| 74 | IKBKE | 0.80180213 |
| 75 | MAP3K1 | 0.79702443 |
| 76 | EPHB1 | 0.79378130 |
| 77 | IRAK1 | 0.77417789 |
| 78 | GRK5 | 0.77319484 |
| 79 | ITK | 0.74702527 |
| 80 | CCNB1 | 0.73424140 |
| 81 | RPS6KB2 | 0.73043589 |
| 82 | EIF2AK3 | 0.72508603 |
| 83 | FRK | 0.72116926 |
| 84 | PINK1 | 0.70675526 |
| 85 | FGR | 0.70638596 |
| 86 | SIK2 | 0.69968235 |
| 87 | DAPK2 | 0.69344549 |
| 88 | MAP3K3 | 0.69343014 |
| 89 | TNK2 | 0.68245334 |
| 90 | RPS6KA4 | 0.67773797 |
| 91 | PDK3 | 0.67177305 |
| 92 | PDK4 | 0.67177305 |
| 93 | NTRK1 | 0.66896460 |
| 94 | ADRBK2 | 0.66772971 |
| 95 | PDGFRA | 0.66718728 |
| 96 | PRKD3 | 0.65843795 |
| 97 | SIK1 | 0.64465964 |
| 98 | HIPK2 | 0.63833757 |
| 99 | * DAPK1 | 0.62222131 |
| 100 | TIE1 | 0.61965835 |
| 101 | CHUK | 0.61029335 |
| 102 | CAMKK1 | 0.60908558 |
| 103 | PRKCH | 0.60528037 |
| 104 | ABL2 | 0.60330583 |
| 105 | EIF2AK1 | 0.60209562 |
| 106 | ACVR1B | 0.59913263 |
| 107 | BMPR1B | 0.59324428 |
| 108 | STK24 | 0.58580839 |
| 109 | PIM1 | 0.58420421 |
| 110 | STK16 | 0.58340673 |
| 111 | NEK2 | 0.58320239 |
| 112 | MATK | 0.56967445 |
| 113 | NEK1 | 0.56598050 |
| 114 | MINK1 | 0.56199394 |
| 115 | TGFBR2 | 0.55851562 |
| 116 | LMTK2 | 0.55570784 |
| 117 | ABL1 | 0.55060762 |
| 118 | LCK | 0.54875239 |
| 119 | TAOK3 | 0.54789598 |
| 120 | OBSCN | 0.53037810 |
| 121 | MST1R | 0.52164176 |
| 122 | MAP4K2 | 0.51449429 |
| 123 | CSK | 0.51313584 |
| 124 | TLK1 | 0.50695739 |
| 125 | TGFBR1 | 0.50576439 |
| 126 | BRSK1 | 0.50300577 |
| 127 | MAP3K2 | 0.50157413 |
| 128 | IGF1R | 0.50001578 |
| 129 | NEK9 | 0.48334797 |
| 130 | PDK1 | 0.48305482 |
| 131 | RPS6KA2 | 0.48087612 |
| 132 | PRKD1 | 0.47595174 |
| 133 | HCK | 0.46935025 |
| 134 | MAP2K1 | 0.44878357 |
| 135 | BLK | 0.44644429 |
| 136 | PAK3 | 0.44381675 |
| 137 | CSNK1G3 | 0.44342943 |
| 138 | PRKCI | 0.43106904 |
| 139 | MAP3K14 | 0.43020536 |
| 140 | CDK6 | 0.42880903 |
| 141 | DYRK3 | 0.42716755 |
| 142 | EGFR | 0.41578223 |
| 143 | PHKG1 | 0.40881749 |
| 144 | PHKG2 | 0.40881749 |
| 145 | TXK | 0.39233856 |
| 146 | PTK2 | 0.38938323 |
| 147 | UHMK1 | 0.38802974 |
| 148 | MAP2K4 | 0.38716794 |
| 149 | TRPM7 | 0.37502986 |
| 150 | MAP2K6 | 0.37106567 |
| 151 | ADRBK1 | 0.35645509 |
| 152 | FYN | 0.34212174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.15260927 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88377409 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.84473127 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.71227286 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.56530525 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.18113801 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.18001465 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09713820 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.09136045 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.04898216 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92558344 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84090294 |
| 13 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.80216074 |
| 14 | Shigellosis_Homo sapiens_hsa05131 | 1.68197213 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67280381 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64889755 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64504840 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58986067 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57731352 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56015419 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55541714 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55272365 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55170543 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54197006 |
| 25 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.51813880 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51096276 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.48628033 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44959512 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.44525898 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.44221790 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.44084892 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.41221861 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.37990989 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37730249 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37471218 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35717003 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.34377836 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30760452 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29619644 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27748537 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24510873 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.24083282 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22948454 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22947706 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21571700 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21379770 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19374677 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17770562 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.14152436 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13992780 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13168382 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.09274618 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08857982 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04482760 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02752555 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01999209 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01055912 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00540552 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99507452 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99275595 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.98203639 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.98100678 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98043795 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97794533 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96873177 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96848358 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.96510586 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.95690543 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95551713 |
| 70 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94412314 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.93490741 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92709695 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90978808 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90095123 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.89726785 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.88445874 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87938874 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87834698 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87107792 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86456761 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85569004 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84970683 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84135550 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83129641 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82564915 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82416065 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82034759 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81232685 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.80875970 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80545165 |
| 91 | Protein export_Homo sapiens_hsa03060 | 0.79357705 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78560668 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78294444 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.76822532 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75231154 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75107334 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74513960 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74298829 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.72278026 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71307781 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70904343 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70554211 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69518567 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69381329 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68032281 |
| 106 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67673244 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67383172 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67132331 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66160884 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65979549 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65711168 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65413613 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65283131 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65212330 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65023637 |
| 116 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63525525 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.63444796 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62324415 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62166811 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61221383 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60994836 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.59245138 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58843977 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58503321 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57632481 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57395237 |
| 127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57388358 |
| 128 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57240870 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56089038 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56055090 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55372940 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54631576 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54504500 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54410664 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53186426 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52957764 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51995590 |
| 138 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51879777 |
| 139 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50050266 |
| 140 | Insulin secretion_Homo sapiens_hsa04911 | 0.49882906 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48220315 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47075702 |
| 143 | RNA polymerase_Homo sapiens_hsa03020 | 0.46802020 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46259882 |
| 145 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46041099 |
| 146 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44874313 |
| 147 | * Regulation of autophagy_Homo sapiens_hsa04140 | 0.43957453 |
| 148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43920011 |
| 149 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43473401 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41212992 |
| 151 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41157966 |
| 152 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39781673 |
| 153 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37464329 |

